Rowe, Christopher W. http://orcid.org/0000-0002-9652-6562
Faulkner, Sam
Paul, Jonathan W.
Tolosa, Jorge M.
Gedye, Craig
Bendinelli, Cino
Wynne, Katie
McGrath, Shaun
Attia, John
Smith, Roger
Hondermarck, Hubert
Funding for this research was provided by:
Hunter New England Local Health District (Clinical Research Fellowship)
Hunter Cancer Research Alliance (Biomarkers and Targeted Therapies Grant)
Australian Government Research Training Program (Scholarship)
Article History
Received: 3 June 2019
Accepted: 13 November 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: This study was prospectively approved by the Hunter New England Local Health District Human Research Ethics Committee (HREC/16/HNE/247) and all participants provided written informed consent to participate.
: All participants provided written informed consent for study data to be published.
: HH holds intellectual property for the use of proNGF as a diagnostic test in cancer. The other authors report nothing to disclose.